Osteoporosis Prevention in Menopause: Protecting Bone After 45

Faster than most women are told, and in a much narrower window. The SWAN study - the Study of Women's Health Across the Nation, which followed a multi-ethnic cohort of midlife women for years - mapped bone loss precisely against the timing of the final menstrual period. What they found was not a gentle decline. It was a cliff.

Bone mineral density at the lumbar spine was essentially stable until about one year before the final menstrual period (FMP). Then it dropped at roughly 1.8-2.3% per year through about two years after the FMP, before slowing again. Across the whole transition, women lost approximately 10% of spine bone density and around 7% at the femoral neck (Greendale et al., Journal of Bone and Mineral Research 2012).

The driver is estrogen withdrawal. Estrogen restrains osteoclasts, the cells that break down bone, so when estrogen falls the demolition crew outpaces the construction crew. Bone is living tissue in constant turnover; menopause tips the balance toward net loss.

This matters because the outcome is not an abstract number. Roughly one in two women over 50 will experience a fracture related to osteoporosis in her remaining lifetime. Hip fractures in particular carry serious consequences for independence and mortality in older adults.

The encouraging part: the window is identifiable. If you are in the two or three years around your final period, you are in the highest-leverage moment of your bone life. What you do now compounds.

Standard guidance in the U.S. is a DEXA scan - dual-energy X-ray absorptiometry, the standard bone density test - at age 65 for all women, and earlier for women with risk factors. Given the SWAN timing data, many clinicians now argue for a baseline earlier, around the menopause transition itself, particularly if you have risk factors.

Risk factors that justify an earlier scan include a parental hip fracture, a previous fragility fracture as an adult, low body weight or a low BMI, smoking, heavy alcohol use, long-term glucocorticoid (steroid) use, rheumatoid arthritis, early menopause before age 45, and certain conditions affecting nutrient absorption.

Your result comes back as a T-score comparing your bone density to a healthy young adult. A T-score of -1.0 or above is normal. Between -1.0 and -2.5 is osteopenia, meaning lower than ideal but not osteoporosis. At -2.5 or below is osteoporosis.

A baseline is valuable even if it comes back normal, because the useful information is the *rate of change* over time. A single scan at 65 tells you where you are. Two scans a decade apart tell you what your bone is doing.

One caution about the numbers: a T-score is a snapshot of density, not of bone quality or fracture risk on its own. Tools like FRAX combine density with clinical risk factors to estimate ten-year fracture probability, and that combined figure is what treatment decisions usually rest on.

Load does. Bone responds to force, and the force has to be meaningful - which means heavy resistance training and impact, not walking.

The clearest evidence comes from the LIFTMOR trial, in which postmenopausal women with low bone mass performed just 30 minutes twice a week of high-intensity resistance and impact training - heavy deadlifts, overhead press, back squats, and jumping chin-ups with drop landings. After eight months, the training group increased lumbar spine bone mineral density by 2.9% and femoral neck density by 0.3%, while the control group lost bone at both sites (Watson et al., JBMR 2018). Importantly, the protocol was supervised and the adverse event rate was very low.

The key words are high-intensity and site-specific. Bone only adapts where the load is applied, so a program that loads the spine and hips is what protects the spine and hips. Light weights for high reps do not produce the same signal.

Impact matters too. Hopping, skipping, or stair descents create ground reaction forces that stimulate bone. Even 10-20 hops a day, done consistently, has evidence behind it for hip bone density in premenopausal and early postmenopausal women.

Walking is not enough on its own for bone, though it is excellent for everything else. Adding load helps - our guide to [weighted vest walking for bone density](/blog/weighted-vest-walking-menopause-bone-density-guide) covers how to do that safely. And for the broader case for lifting in midlife, see [resistance training for menopause](/blog/resistance-training-for-menopause-why-lifting-matters).

If you have existing osteoporosis or spinal fractures, do not self-prescribe heavy loading or forward-flexion movements. Get a referral to a physiotherapist who works with bone health.

For women over 50, the standard target is 1,200 mg of calcium daily and 800-1,000 IU of vitamin D, according to the Bone Health and Osteoporosis Foundation. Both numbers include what you get from food, which is where most of it should come from.

Calcium from food is better absorbed and carries less cardiovascular concern than high-dose supplements. Good sources: dairy (a cup of milk or yogurt is roughly 300 mg), fortified plant milks, canned sardines and salmon with bones, tofu set with calcium, kale, bok choy, and almonds. Most women get 600-800 mg from a normal diet, which means a modest supplement of 500 mg often closes the gap - not the 1,000-1,200 mg megadose some people take.

Split supplemental calcium into doses of 500 mg or less, because absorption drops above that in a single sitting.

Vitamin D matters because without it you absorb calcium poorly regardless of intake. Sun exposure is unreliable above certain latitudes and in winter, so supplementation is common. If you are unsure, a blood test for 25-hydroxyvitamin D gives you a real answer rather than a guess. Our full guide to [calcium and vitamin D for menopause](/blog/calcium-and-vitamin-d-for-menopause-how-much-you-need) covers dosing and testing in detail.

Do not overlook protein. The old idea that high protein leaches calcium from bone has not held up; current evidence suggests adequate protein supports bone density, particularly alongside sufficient calcium. Aim for roughly 1.0-1.2 g per kilogram of body weight, higher if you are actively losing weight. See [protein in menopause](/blog/protein-in-menopause-how-much-to-prevent-muscle-loss).

Other levers: vitamin K2 and magnesium have supporting roles but weaker fracture evidence. Smoking and heavy alcohol both directly harm bone and are worth addressing before any supplement.

Yes, and this is one of the least disputed findings in the entire hormone therapy literature. In the Women's Health Initiative, estrogen therapy reduced hip fractures by roughly a third and reduced vertebral and total fractures as well - and it did so in a general population of postmenopausal women, not only those with osteoporosis. Few interventions have that quality of fracture evidence.

Bone protection is an approved indication for hormone therapy for prevention of postmenopausal osteoporosis in appropriate candidates. The catch is that protection persists only while you take it; bone loss resumes after stopping, though not usually faster than the normal postmenopausal rate.

The timing hypothesis matters here. The risk-benefit profile is most favorable for women who start within ten years of their final period and under age 60. Starting hormone therapy in your seventies is a different calculation entirely. Our guides to [HRT and breast cancer risk](/blog/hrt-and-breast-cancer-risk-what-the-whi-data-actually-shows) and [how long you can stay on HRT](/blog/how-long-can-you-stay-on-hrt-duration-explained) cover the full picture.

If HRT is not right for you, other options exist. Bisphosphonates are first-line drug treatment for established osteoporosis. Denosumab, and anabolic agents like teriparatide and romosozumab, are used for higher-risk cases. These are prescriber decisions based on your fracture risk, not choices to make from an article.

What is worth knowing is that "I can't take HRT" does not mean "there is nothing I can do." It means the conversation moves to a different set of tools, plus the loading and nutrition work that helps regardless.

This is general information, not medical advice - your bone plan should be built with a clinician who knows your history, your DEXA results, and your fracture risk.

It adds a second stressor on top of the menopause one, and the combination deserves attention rather than alarm. Weight loss of any kind - dieting, surgery, or medication - is associated with some bone mineral density loss. Part of this is mechanical: less body mass means less daily load on the skeleton. Part is nutritional: eating less usually means less calcium, less protein, and less of everything else.

GLP-1 medications produce substantial and often rapid weight loss - 14.9% over 68 weeks in STEP 1, 20.9% over 72 weeks in SURMOUNT-1. For a woman going through the transmenopausal bone loss window at the same time, those two curves overlap in an unhelpful way. Our dedicated article on [GLP-1 and bone density in menopause](/blog/glp1-bone-density-menopause-protecting-your-bones) covers what the evidence currently shows and where it is still thin.

The practical response is not to avoid the medication. It is to do the protective work deliberately: keep protein high, keep calcium and vitamin D adequate even when appetite is low, and keep loading the skeleton with resistance training throughout. These are the same three things that protect muscle, which is not a coincidence - muscle pulls on bone, and losing muscle costs you bone.

Under-eating is the specific risk to watch. When appetite disappears, calcium and protein intake often fall well below target without anyone noticing. [Eating enough on GLP-1 in menopause](/blog/eating-enough-on-glp1-during-menopause-calorie-floor) and [supplements on GLP-1 during menopause](/blog/supplements-on-glp1-during-menopause-what-you-actually-need) cover how to keep the floor intact.

If you are managing both at once, a baseline DEXA before or early in treatment is a reasonable thing to ask for. It gives you a starting line to measure against.